Varsity Team Rally III raises more than $100,000 for Masonic Cancer Center research
On September 18, the Cancer and Cardiovascular Research Building was the site of Varsity Team Rally III, a one-evening event that raised more than $100,000 for the Genomic Signatures for Colorectal Cancer project at Masonic Cancer Center. Emceed by U of M Athletic Director Norwood Teague, the event brought together community supporters and donors to hear from cancer researchers and tour the new facility. President Eric Kaler and Masonic Cancer Center Director Douglas Yee, M.D., were also part of the program. Read more.
Hyundai Hope on Wheels awards grant to Masonic Cancer Center researcher
Logan Spector, Ph.D., is the recipient of a two-year $250,000 grant from Hyundai Hope on Wheels to study the genetic causes of osteosarcoma in children. The grant will be used to examine the protein-coding portions of the genomes (known as exomes) of about 100 osteosarcoma patients and their parents. By comparing patients' exomes to their parents' new mutations will be located. Genes where these mutations cluster will be considered very likely to be involved in causing osteosarcoma. Knowing the genetic causes of osteosarcoma may suggest new therapies and screening strategies to catch tumors earlier and improve patient outcomes.
New breast cancer drug combats early-stage breast cancer
Douglas Yee, M.D., Masonic Cancer Center director and a University of Minnesota Physicians breast cancer specialist, appeared on Fox 8 last week to discuss a new drug that combats breast cancer in its earliest stages. Read more.
U of M researcher aims to improve golden retriever cancer diagnostics, treatment as part of new $1 million grant
Jaime Modiano, V.M.D., Ph.D., a canine cancer researcher from the Masonic Cancer Center, University of Minnesota, is one of a trio of researchers receiving a new $1.1 million g
rant from the American Kennel Club Canine Health Foundation and the Golden Retriever Foundation to investigate improved cancer diagnostics and treatments for golden retrievers and, by ex
tension, humans. Read more.
U celebrates grand opening of Cancer and Cardiovascular Building
U of M researchers find novel gene correction model for Epidermolysis Bullosa
A research team led by pediatric blood and marrow transplantation experts Mark Osborn, Ph.D. and Jakub Tolar, M.D., Ph.D. from the Masonic Cancer Center, University of Minnesota, have discovered a remarkable new way to repair genetic defects in the skin cells of patients with the skin disease epidermolysis bullosa. Read more.